Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau0 sites30 target enrollmentJanuary 2021

ConditionsArtery Disease, Peripheral Aortic Diseases Carotid Artery Diseases Other Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Artery Disease, Peripheral
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment: 30
Primary Endpoint: Change on baseline Activated Clotting Time with comorbidities
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Check whether patients with higher comorbidity and risk of complication, estimated using the V (p) -POSSUM score, ACS NSQIP and the ASA classification, present higher baseline activated clotting time values.

Registry

clinicaltrials.gov

Start Date

January 2021

End Date

June 2021

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients undergoing vascular surgery requiring intraoperative heparinization

Exclusion Criteria

•Pregnant women
•SARS-CoV-2 PCR positive (performed 24-72h prior to surgery)
•Severe plaquetopenia \<50,000

Outcomes

Primary Outcomes

Change on baseline Activated Clotting Time with comorbidities

Time Frame: 1 day - surgery day

Activted Clotting Time will be measured with Haemocron Machine just before surgery. Comorbidities will be measured with V(p)Possum, AC NSQUIP and ASA scales.